In many of the above studies, patients were reported to have subnormal B12 levels
"With seven additional Phase 3 readouts expected in 2026, we believe retatrutide could become an important option for patients with significant weight loss needs and certain complications, including knee osteoarthritis." While Eli Lilly's triple agonist is yet to be licensed, its main competitor Novo Nordisk (the maker of Ozempic) announced back in March 2025 that it had reached a licensing agreement with Hong Kong-based pharmaceutical lab The United Laboratories
The data obtained is anonymized as much as possible
Vitamin B5 (pantothenic acid): Pantothenic acid is involved with cellular energy metabolism and synthesizing the neurotransmitter acetylcholine, which is involved with muscle contraction, memory, motivation, and learning
Benefits seen there may not generalize to non-diabetic populations
Due to the cost of semaglutide, particularly in the United States, limited cost effectiveness analyses have demonstrated unfavorable incremental cost-effectiveness ratios for semaglutide relative to phentermine-topiramate as an alternative antiobesity medication in adolescents [41]